Ascendis Pharma A/S
ASND | NASDAQ
$250.88
-$0.39 (-0.16%)
Nov 2, 2026, 11:50 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 344.9M | 250.66M | 245.18M | 213.63M | 158.05M | 100.95M | 173.92M | 57.83M | 36M | 95.89M | 137.7M | 48.03M | 47.39M | 33.59M | 22.9M | 15.29M | 6.16M | 6.83M | 4.9M | 1.11M | 1.02M | 746K |
Cost of Revenue | 32.3M | 21.62M | 27.2M | 22.35M | 31.45M | 17.52M | 14.02M | 11.2M | 11.47M | 7.57M | 19.46M | 7.39M | 12.93M | 4.62M | 5.11M | 1.69M | 1.09M | 4.25M | 3.52M | n/a | n/a | n/a |
Gross Profit | 312.61M | 229.03M | 217.98M | 191.28M | 126.6M | 83.44M | 159.89M | 46.63M | 24.53M | 88.33M | 118.25M | 40.65M | 34.46M | 28.97M | 17.78M | 13.6M | 5.07M | 2.58M | 1.37M | 1.11M | 1.02M | 746K |
Operating Income | 63.43M | 25.22M | 9.8M | 11M | -52.95M | -104.21M | 383K | -96.74M | -133.26M | -49.15M | -36.61M | -134.41M | -140.84M | -143.69M | -147.39M | -144.51M | -141.89M | -128.03M | -112.58M | -96.93M | -117.63M | -124.65M |
Interest Income | 20.3M | 4.59M | 23.83M | 3.33M | 55.06M | 28.85M | -66.55M | 28.28M | 49.05M | 3.58M | n/a | 4.14M | 35.76M | 45.14M | n/a | 20.33M | 71.13M | 13.04M | n/a | 21.32M | 145K | 34.43M |
Pretax Income | 233.9M | -48.97M | -26.45M | -57.37M | -35.01M | -93.57M | -37.38M | -98.18M | -109.15M | -128.53M | -81.09M | -161.58M | -121.86M | -109.62M | -202.07M | -169.12M | -81.37M | -125.26M | -106.18M | -80.34M | -134.44M | -62.98M |
Net Income | 210.4M | 639.69M | -33.25M | -60.99M | -38.86M | -94.63M | -38.47M | -99.2M | -109.38M | -131.04M | -86.88M | -162.22M | -121.43M | -110.91M | -207.42M | -168.96M | -81.32M | -125.5M | -106.06M | -80.35M | -134.37M | -62.79M |
Selling & General & Admin | 174.52M | 146.18M | 133.2M | 111.69M | 105.71M | 95.65M | 78.78M | 68.13M | 74.31M | 66.78M | 63.98M | 62.51M | 70.28M | 66.54M | 56.55M | 60.67M | 56.58M | 47.42M | 48.3M | 39.28M | 35.35M | 37.25M |
Research & Development | 74.65M | 57.63M | 74.98M | 66.88M | 71.99M | 86.6M | 79.3M | 73.54M | 83.48M | 70.69M | 90.88M | 111.44M | 105.02M | 106.11M | 108.62M | 97.43M | 90.38M | 83.19M | 65.65M | 58.76M | 83.31M | 88.15M |
Other Expenses | n/a | n/a | n/a | 1.72M | 1.85M | 5.4M | 1.43M | 1.7M | n/a | n/a | n/a | 1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 |
Operating Expenses | 249.17M | 203.81M | 208.18M | 180.28M | 179.55M | 187.65M | 159.51M | 143.38M | 157.79M | 137.47M | 154.86M | 175.05M | 175.3M | 172.65M | 165.17M | 158.1M | 146.97M | 130.61M | 113.96M | 98.05M | 118.65M | 125.4M |
Interest Expense | 14.41M | 68.36M | 61.4M | 19.72M | 33.02M | 44.79M | -56.63M | 25.35M | 19.62M | 77.16M | 68.55M | 24.52M | 9.33M | 9.84M | 71.67M | 41.25M | 9.43M | 5.4M | 45.23M | 877K | 12.14M | 869K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 281.47M | 225.44M | 235.38M | 202.64M | 211M | 205.17M | 173.53M | 154.58M | 169.26M | 145.04M | 174.31M | 182.44M | 188.23M | 177.27M | 170.28M | 159.8M | 148.05M | 134.86M | 117.48M | 98.05M | 118.65M | 125.4M |
Income Tax Expense | 23.51M | -688.66M | 6.79M | 3.62M | 3.85M | 1.06M | 1.09M | 1.02M | 229K | 2.51M | 5.79M | 645K | -429K | 1.3M | 5.35M | -167K | -47K | 241K | -114K | 5K | -68K | -191K |
Shares Outstanding (Basic) | 64.34M | 61.68M | 61.38M | 60.99M | 60.45M | 60.02M | 59.79M | 58.57M | 57.35M | 56.88M | 56.61M | 56.27M | 56.22M | 56.09M | 55.99M | 55.83M | 55.81M | 56.72M | 53.85M | 54.64M | 53.85M | 53.76M |
Shares Outstanding (Diluted) | 68.32M | 64.52M | 61.38M | 60.99M | 63.91M | 60.02M | 59.79M | 58.57M | 57.35M | 56.88M | 56.61M | 56.27M | 56.22M | 56.09M | 55.99M | 55.83M | 55.81M | 56.72M | 53.85M | 54.64M | 53.85M | 53.76M |
EPS (Basic) | 3.27 | 10.37 | -0.54 | -1 | -0.64 | -1.58 | -0.64 | -1.69 | -1.91 | -2.30 | -1.53 | -2.88 | -2.16 | -1.98 | -3.70 | -3.03 | -1.46 | -2.21 | -1.97 | -1.47 | -2.50 | -1.17 |
EPS (Diluted) | 3.08 | 9.91 | -0.54 | -1 | -0.82 | -1.58 | -0.64 | -1.69 | -1.91 | -2.30 | -1.53 | -2.88 | -2.16 | -1.98 | -3.70 | -3.03 | -1.46 | -2.21 | -1.97 | -1.47 | -2.50 | -1.17 |
EBITDA | 68.08M | 23.68M | 39.72M | -53.35M | 2.32M | -44.23M | -37.89M | -71.13M | -87.51M | -46.89M | -67.69M | -132.32M | -107.88M | -103.28M | -128.95M | -123.24M | -67.47M | -115.44M | -100.57M | -75.68M | -118.68M | -58.4M |
EBIT | 63.43M | 19.39M | 34.94M | -57.37M | -1.99M | -48.78M | -42.37M | -72.83M | -89.53M | -51.37M | -72.66M | -137.06M | -112.53M | -107.83M | -130.4M | -127.88M | -71.93M | -119.86M | -104.85M | -79.47M | -122.3M | -62.11M |
Depreciation & Amortization | 4.64M | 4.29M | 4.78M | 4.02M | 4.31M | 4.55M | 4.48M | 1.7M | 2.02M | 4.5M | 4.85M | 4.88M | 4.63M | 4.55M | 1.44M | 4.64M | 4.46M | 4.48M | 4.3M | 3.85M | 3.68M | 3.81M |
Add to Watchlist
Select watchlists to add or remove ASND